24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
10/05/2017
Barcelona Synchrotron Park’s Commitment to Nature and Biodiversity
04/05/2017
Reference research centres in the environment of the Barcelona Synchrotron Park
27/04/2017
SMEs discover the potential of the Barcelona Synchrotron Park
18/04/2017
Stradivarius has settled in the Barcelona Synchrotron Park
05/04/2017
The BSP is candidate to host the European Medicines Agency
30/03/2017
ALBA Synchrotron Gives Support to Companies